FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Board Chairs/Vice Chairs Annual Long-range Planning Meeting
January 11, 2019

The Annual Long Range Planning meeting has been scheduled for Friday, May 31, 2019. Please click here for more information. Continue reading


EXECUTIVE ORDERS ISSUED BY GOVERNOR SCOTT
December 27, 2018

Please click here for more information regarding extended license expiration deadlines for Registered Pharmacy Technician and Consultant Pharmacist. Continue reading